Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study-Reference-Cited by-同舟云学术

Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study

Published:2017-11-15 Issue:1 Volume:8 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Kumar Hemant,Ha Doo-Hoe,Lee Eun-Jong,Park Jun Hee,Shim Jeong Hyun,Ahn Tae-Keun,Kim Kyoung-Tae,Ropper Alexander E.,Sohn Seil,Kim Chung-Hun,Thakor Devang Kashyap,Lee Soo-Hong,Han In-Bo

Funder

Korea Healthcare Technology Research & Development Project, Ministry for Health & Welfare Affairs

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13287-017-0710-3.pdf

Reference40 articles.

1. Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, Williams G, Smith E, Vos T, Barendregt J, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:968–74.

2. Oehme D, Goldschlager T, Ghosh P, Rosenfeld JV, Jenkin G. Cell based therapies used to treat lumbar degenerative disc disease: a systemic review of animal studies and human clinical trials. Stem Cells Int. 2015;2015:946031.

3. Dagenais S, Tricco AC, Haldeman S. Synthesis of recommendations for the assessment and mangement of low back pain from recent clinical practice guidelines. Spine J. 2010;10(6):514–29.